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Abstract
HSV-1 viral capsid maturation and egress from the nucleus constitutes a self-controlled process of interactions 
between host cytoplasmic membrane proteins and viral capsid proteins. In this study, a member of the tetraspanin 
superfamily, CTMP-7, was shown to physically interact with HSV-1 protein VP26, and the VP26-CTMP-7 complex was 
detected both in vivo and in vitro. The interaction of VP26 with CTMP-7 plays an essential role in normal HSV-1 
replication. Additionally, analysis of a recombinant virus HSV-1-UG showed that mutating VP26 resulted in a decreased 
viral replication rate and in aggregation of viral mutant capsids in the nucleus. Together, our data support the notion 
that biological events mediated by a VP26 - CTMP-7 interaction aid in viral capsid enveloping and egress from the cell 
during the HSV-1 infectious process.
Background
Herpes simplex virus type 1 (HSV-1) is a double-stranded
DNA virus with a 152 kb genome that has the capacity to
encode more than 80 structural and non-structural viral
proteins during its lifecycle in the cell [1]. Its structural
proteins generate a dodecahedron protein capsid in the
nucleus via their protein-protein interactions [2]. Despite
the variety of capsid shapes [3], the basic general struc-
tures are composed of interior scaffold polypeptides,
principally VP22a, VP21, viral protease VP24 and capsid
shell proteins VP5, VP19c, VP23 and VP26 [4]. These
proteins tend to assemble into viral capsid hexon and
penton structures [5] through a specific mechanism that
is not well understood. VP5 is the largest capsid protein
and the major component of the capsid shell [6], while
VP26 is the smallest capsid protein. VP26 localizes to the
surface of penton and hexon capsids as a redundant com-
ponent [7] and is likely to interact physically with VP5 [8].
Intriguingly, it has been reported that HSV-1 replication
and proliferation are not directly affected by the absence
of VP26 [9], although the protein is present in viral
capsids in high copy numbers (>900/capsid)[10]. How-
ever, some studies indicate that the replication rate of
viral mutants lacking the VP26-encoding gene UL35 is
decreased by 2 - 30 fold in various cell lines[11,12]. Thus,
this viral protein potentially has a functionally significant
role in the HSV-1 infectious process.
Studies on VP26 functions have demonstrated interac-
tions of VP26 with cytoplasmic dynein light chains RP3
and Tctex 1 when expressed artificially from vectors [13].
Furthermore, VP26 has also been reported to recruit and
bind to procapsid in its mature state in an ATP-depen-
dent fashion [14]. Such interactions suggest a possible
functional role of VP26 in the transport of viral capsids in
the cell[13]; however, this conclusion was not entirely
supported by recent studies [15]. Additionally, it is sug-
gested that VP26 on the viral capsid surface might inter-
act with intracellular molecules. Katinka and colleagues
used a recombinant HSV-1 virus containing a green fluo-
rescent protein (GFP)-coding sequence fused to UL35 to
demonstrate that the fluorescent capsid proteins aggre-
gated in compartments of the cytoplasmic membrane
close to the nucleus[16]. The analysis of HSV-1 viral
capsid egress from the nucleus indicates that nuclear
membrane enveloping is required for these naked capsids
to be transported to the perinuclear cisterna [17]. Subse-
quently, the de-enveloped capsids are wrapped again by
organelles such as the Golgi and are gradually moved
toward the cytoplasmic membrane and assembled [18].
Together, these data raise the possibility of interactions
between protein molecules in viral capsids and compo-
nents of the cytoplasmic membrane. The significance of
host proteins from the cytoplasmic membrane that may
interact with viral capsid proteins and become incorpo-
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rated into the viral envelope in the process of HSV-1
capsid budding merits further investigation.
As demonstrated by cellular and molecular studies, the
tetraspanin superfamily member proteins are cellular
membrane proteins type III found on the cytoplasmic
membrane [19]. Such proteins play essential biological
roles with distinctive and differential physiological effects
on the viral budding process [20]. In the work described
herein, we show that VP26 interacts specifically with tet-
raspanin superfamily member, cellular tetraspanin mem-
brane protein 7 (CTMP-7) on the cytoplasmic
membrane. This interaction may directly affect the envel-
oping of the HSV-1 capsid shell and contribute to con-
trolling the process and efficiency of virus assembly and
egress from the cell.
Results
Evidence of VP26 interaction with CTMP-7
F i v e  p r o t e i n s  i n t e r a c t i n g  w i t h  V P 2 6  w e r e  i d e n t i f i e d  b y
yeast two-hybrid analysis using VP26 as the bait protein
and a human embryonic lung mRNA library as the target
(Supplementary Table 1). These interactions were further
confirmed by a β-gal activity assay (Fig.1a). One of the
VP26 interacting proteins is a cellular membrane protein
type III and is a homologue of tetraspanin family member
cellular tetraspanin membrane protein 7 (CTMP-7, Gen-
Bank accession number is NP_004606)). CTMP-7 is com-
posed of 249 amino acid residues (28 kDa) and includes a
typical tetraspanin-enriched domain (TEM) (Fig. 1b). We
further confirmed binding of CTMP-7 to VP26 in HSV-1
infected human embryonic lung fibroblasts by co-immu-
noprecipitation with anti-CTMP-7 antibody and anti-
VP26 antibody (Fig. 1c). Analysis of the CTMP-7 - VP26
interaction by β-gal activity assay suggested that the
interaction involved the C-terminal portion of CTMP-7
(Fig.1d).
Expression and distribution of CTMP-7 in normal and HSV-1 
infected cells
The fusion protein of CTMP-7 and GFP encoded by
eukaryotic expression vector pGFP-CTMP was expressed
by transient transfection in Vero cells. Visualization of the
expressed CTMP-7-GFP fusion protein in normal cells
revealed aggregation in punctate spots on the nuclear and
cytoplasmic membranes similar to the pattern exhibited
by other tetraspanin family members (Fig.2a, left at
upper)[21]. In contrast, the fluorescent punctate distribu-
tion was altered drastically in HSV-1 infected Vero cells
expressing the CTMP-7-GFP fusion protein. Bright punc-
tate spots were distributed from the nuclear membrane
to the cytoplasm at 24 h post-infection (Fig.2a, right at
upper). Compared with control cells expressing fluores-
cent GFP protein where no significant alteration was
visualized (Fig 2a down row). Flow cytometric analysis
showed an obvious decrease of fluorescence intensity in
cells expressing tetraspanin-GFP fusion protein at 30 h
post HSV-1 infection (Fig.2b).
CTMP-7 molecules are present in purified HSV-1 virions
Upon observing that fluorescently tagged CTMP-7 mole-
cules disappeared from nuclear and cytoplasmic mem-
branes in HSV-1 infected cells, we performed a Western
b l o t  a s s a y  t o  d e t e c t  C T M P - 7  i n  i n f e c t e d  c e l l  d e b r i s ,
infected cell culture supernatant, and in concentrated,
purified virus isolated by sucrose density gradient centrif-
ugation. Intriguingly, CTMP-7 protein was detected in
infected cell debris, and a low level of CTMP-7 protein
was detected in purified viral particles showing 27 kDa
band in Western blot by antibody against-CTMP-
7(Fig.3a), and the other Western blot analysis with anti-
HSV1 antibody confirmed the band did not represent a
viral component (Fig.3b). Since the purified viral particles
were harvested intact from the gradient, this result sug-
gests that capsid enveloping and entry into viral assembly
may be attributed to CTMP-7 binding of VP26.
Inhibition of CTMP-7 expression decreases viral replication
It has been demonstrated that proliferation and replica-
tion of an HSV-1 mutant lacking the VP26 encoding gene
were significantly delayed compared to wild-type virus
[11]. If the potential interaction of VP26 with CTMP-7 is
significant, similar effects on proliferation and replication
should be observed in the absence of CTMP-7. In order
to investigate the hypothesized importance of CTMP-7,
the plasmid pGE-CTMP was transfected into human
embryonic lung fibroblast cells (KMB-17). Plasmid pGE-
CTMP expresses siRNAs directed against the 3'-UTR and
coding sequences of the CTMP-7 mRNA. The knock-
down effects of pGE-CTMP were confirmed by examin-
ing CTMP-7 protein levels in a Western blot (Fig.4a).
Compared to cells transfected with the control plasmid
pGE-Neg, viral growth was significantly decreased 24-36
h post HSV-1 infection in cells transfected with the
siRNA-expressing pGE-CTMP plasmid (Fig. 4b). This
result implies that CTMP-7 is required for efficient HSV-
1 replication and proliferation.
Table 1: Oligonucleotides used in this study
Oligonucleotide Sequence(5'-3'
CMTP-7-fwd ATGGAGACCAAACCTGTG
CMTP-7-rev ACACCATCTCATACTGATTG
VP26-fwd CGTCCCGCAATTTCACCG
VP26-rev GGGCGTCGAAGGTTCTCG
UL35-N-fwd ATGGCCGTCCCGCAATT
UL35-N-rev CACGGCCCCTTGGGT
UL35-C-fwd CGGGAGTTTCTCCGCGG
UL35-C-rev CGAAGGTTCTCGAACGACWang et al. Virology Journal 2010, 7:156
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Figure 1 CTMP-7 is a VP26 interacting protein. a. Binding assay of the proteins and VP26. The positive control was the fusion yeast containing 
pGBK-p53 and pACT-LT. The negative control was the fusion yeast containing pGBK-Lam and pACT-LT. b. Amino acid sequence features of CTMP-7. 
The amino acid sequence of CTMP-7 contains the typical tetraspanin-enriched domain with four transmembrane regions (shown in red) and a topo-
logical domain (shown in black). c. Co-immunoprecipitation of the VP26 and CTMP-7 interaction complex and immunoblot by anti-CTMP-7 antibody. 
Vero cells transfected by VP26 and CTMP gene and labeled with 35S-methionine were lysed in RIPA buffer and interacted with anti-VP26 or anti-CTMP 
antibodies. Lane 1: The immunoprecipitated complexes of cells co-transfected with VP26 and CTMP genes by anti-VP26 antibody; Lane 2: The immu-
noprecipitated complexes of cells co-transfected with VP26 and CTMP genes by anti-CTMP-7 antibody. Lane 3: The immunoprecipitated complexes 
of cells transfected with pcDNA mock by anti-VP26 antibody; and Lane 4: The immunoprecipitated complexes of cells transfected with pcDNA mock 
by anti-CTMP-7 antibody. Lane 5: Control cells lysate; Lane 6: Negative control with normal mouse IgG. d. Mapping the region of CTMP-7 interaction 
with VP26. The plasmids encoding CTMP-7 amino acid residues 1-61, 61-150 and 150-249 were constructed and transfected into yeast Y187. These 
transfected Y187 clones were fused with AH109 transfected with pGBK-VP26. These fused clones were identified on QDO plates and their β-galacto-
sidase activity was analyzed.Wang et al. Virology Journal 2010, 7:156
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Figure 2 Intracellular analysis of CTMP-7 in HSV-1 infected cells. Vero cells were transiently transfected with plasmid pGFP-CTMP or pGFP-N fol-
lowed by HSV-1 infection at 1 MOI, and then observed at 24 h post transfection by fluorescence microscopy without fixation. At 30 h post-infection, 
the cells were trypsinized, washed in PBS and analyzed by flow cytometry. a. Observation of Vero cells transfected with pGFP-CTMP or pGFP-N and 
infected by HSV1 at 24 h post-infection under fluorescence microscope. Upper row: Cells transfected with pGFP-CTMP and infected by HSV-I. Lower 
row: Cells transfected with pGFP-N and infected by HSV-I. b. Cytometric analysis of Vero cells transfected with pGFP-CTMP and pGFP-N followed by 
HSV-1 infection or not at 30 h post-infection. Column 1: Cells transfected with pGFP-N, upper - cells HSV-I infection free; lower - cells at 30 h post-
infection. Column 2: Control cells transfected with pGFP-CTMP with HSV1 infection free, upper is cell at the same time point to 16 h post-infection of 
infective example, lower is cells at the same time point to 30 h post-infection of infective example. Column 3: Cells transfected with pGFP-CTMP and 
followed by HSV1 infection, upper is cell at 16 h post-infection; down is cell at 30 h post-infection.Wang et al. Virology Journal 2010, 7:156
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Reduction of CTMP-7 decreases egress of HSV-1 particles
VP26 is located on the viral capsid surface, while its func-
tionally interacting molecule CTMP-7 is a trans-mem-
brane protein in the cytoplasmic membrane. We
hypothesized that the effect of decreased CTMP-7 levels
on viral replication most likely takes place during the
egress of HSV-1 particles. Therefore, the egress of viral
particles was further examined in cells with CTMP-7
expression inhibited by RNAi. In order to accurately
detect the variations of virus numbers in infected cells,
specific primers were designed to target HSV-1 α-4, TK
and gC genes. These primers were employed to deter-
mine cellular or extracellular viral loads at different infec-
tious stages by using real-time quantitative PCR. The
results showed that the viral loads 12 h post-infection
were similar in cells transfected with pGE-CTMP and
pGE-Neg (Fig.5a). At 24 h post-infection, the viral load in
control cell supernatants was significantly higher than the
intracellular viral load. In contrast, the intracellular viral
load in cells with suppressed CTMP-7 expression was
much higher than that in the supernatant (Fig.5b). By 36
h post-infection of pGE-CTMP-transfected cells, the viral
load was higher in the supernatant than in the cells,
although there were still some differences in the virus lev-
els compared to the control cells (see Fig.5c).
Inhibition of CTMP-7 results in HSV-1 capsids aggregating 
in the cell
The previous experiments demonstrated that viral repli-
cation is similarly affected, i.e., reduced, in cells infected
by HSV-1 viruses in the absence of either VP26 or
CTMP-7. The detailed mechanism of how these proteins
affect HSV-1 replication remains unclear, although the
available evidence suggests that the absence of CTMP-7
Figure 3 Western blot of CTMP-7 molecules in purified HSV-1 vi-
ral particles. a. Immunoblot showing the distribution of cellular 
CTMP-7 protein in HSV-1 infection. KMB-17 cells infected with HSV-1 (1 
MOI) or uninfected were collected at 48 h post-infection and centri-
fuged at 10,000 rpm for 10 min at 4°C to separate debris and superna-
tant. The supernatant from infected cells was concentrated to 1/50 by 
centrifugation at 40,000 rpm for 4 hours at 4°C, re-suspended, and sep-
arated via a sucrose density gradient centrifugation. The fraction with 
highest titer was used in immunoblot. 1: Control cells debris; 2: Control 
cells supernatant; 3: The supernatant from infected cells; 4: The pellet 
from infected cells; 5: Purified virions from sucrose gradient centrifuga-
tion. The antibody in this immunoblot is mouse polyclonal antiserum 
against CTMP-7. b. Western blot analysis with anti-HSV1 antibody. The 
purified virus virion was electrophoresed by 10% SDS-PAGE, trans-
ferred onto nitrocellulose membranes, and used for Western blotting 
analysis with anti-HSV-1 antisera specific for the virus protein at 1:500 
dilution. Signals were detected by an ECL system (Pierce). 1: Control 
cells debris; 2: Purified virions from sucrose gradient centrifugation; 3: 
The supernatant from infected cells; 4: The pellet from infected cells.
Figure 4 Inhibition of CTMP-7 in cells by RNAi delayed the prolif-
eration of HSV-1. a. Expression of CTMP-7 in KMB-17 cells was inhibit-
ed by pGE-CTMP containing siRNA targeted specifically to CTMP-7 
mRNA. Cells transfected by pGE-CTMP or pGE-1 were harvested after 
48 h, and lysates were analyzed by Western blotting using antisera 
raised in mouse immunized with CTMP-7. 1: Cells transfected with 
pGE-1; 2: Cells transfected by pGE-CTMP. b. Inhibition of CTMP-7 ex-
pression by siRNA reduced HSV-1 proliferation in fibroblasts. Growth 
curves of HSV-1 in KMB-17 cells transfected with pGE-CTMP were pro-
duced and analyzed. KMB-17 cells transfected with pGE-1, pGE-CTMP 
plasmid were infected at an MOI of 1 with HSV-1, and incubated at 
37°C. At the indicated times post-infection, samples of cell supernatant 
were removed and the viral titer was determined by microtitrating as-
say. n = 3 for all time points. Error bars represent the standard error of 
the mean.Wang et al. Virology Journal 2010, 7:156
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Figure 5 Reduction of CTMP-7 in cells by RNAi decreased the egress of HSV-1. KMB-17 cells transfected with pGE-Neg or pGE-CTMP plasmid 
were infected at an MOI of 1 with HSV-1 and incubated at 37°C. Viral loads (shown as delta Rn of virus DNA replication) of HSV-1 in KMB-17 cells were 
detected and analyzed by real-time PCR. At the indicated times post infection, samples of cell transfected and infected were harvested and extracted 
for further real-time PCR. The protocol is described in Material and Method. a. Viral loads shown with the copy of α-4, tk and gC genes of HSV1 at 12 
hours post-infection in cells with CTMP-7 expression being inhibited. b. Viral loads shown with the copy of α-4, tk and gC genes of HSV1 at 24 hours 
post-infection in cells with CTMP-7 expression being inhibited. c. Viral loads shown with the copy of α-4, tk and gC genes of HSV1 at 36 hours post-
infection in cells with CTMP-7 expression being inhibited.Wang et al. Virology Journal 2010, 7:156
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affects the egress of viral particles. In attempt to deter-
mine the mechanism, a morphological analysis was per-
formed using electron microscopy to observe the
enveloping process of viral capsids. The HSV-1 capsids
w e r e  o b s e r v e d  a g g r e g a t i n g  i n  c e l l s  i n  w h i c h  C T M P - 7
expression was inhibited by RNAi (Fig.6a). However, in
control cells the capsids were localized separately to the
cytoplasma (Fig.6b). This observation suggests prelimi-
narily that VP26 and CTMP-7 may contribute to the
egress of viral particles by contributing to the process of
enveloping of viral capsids.
A VP26 mutant causes viral capsid aggregation in the cell 
and leads to a decreased viral replication rate
In order to further investigate the biological events in the
viral enveloping process generated by the interactions of
VP26 and cellular CTMP-7, we constructed a viral
mutant, HSV-1-UG, with a GFP-coding sequence fused
to the UL35 gene. In Vero cells infected with HSV-1-UG,
a mutant VP26 was expressed and distributed in fluores-
cent punctate spots throughout the infected cells and
maintained this pattern until 24 h post-infection (see
Fig.7a). Similar observations were found in the mutant
HSV-1 infected HeLa cells and neuroma SH-5YSY cells
(data not shown). However, the kinetic growth rate of this
viral mutant was significantly lower than that of wild-
type HSV-1. Interestingly, when the HSV-1-UG mutant
was used to infect normal human embryonic lung fibro-
blast KMB-17 cells, aggregation of viral capsids in the
cells was observed (Fig.7b). These data support the previ-
ous work performed in our laboratory.
Discussion
The biological events of HSV-1 progeny viral assembly
and maturation during infection constitute a self-con-
trolled process of virion enveloping after assembly of the
capsid [22]. Extensive examination by electron micros-
copy has shown that the HSV-1 capsid shell is incorpo-
rated in the nucleus and subsequently transported toward
the interior nuclear membrane by an unknown mecha-
nism; this process leads to the capsid being enveloped by
the nuclear bi-layer membranes. The interior membrane
is considered the first viral envelope and the exterior
membrane facilitates egress of the enveloped virion from
the nucleus via the cis-network and remains in the cis-
terna of perinuclear space. The virion is then transported
from cisterna to organelles like Golgi in the cytoplasm
where the first incorporated envelope is assumed to de-
envelope [23]. The naked capsids then enter into the
Golgi secretory pathway and are enveloped via binding to
the cytoplasmic membrane, leading to exocytosis and
egress of the whole assembled virus from the cell [24].
Although this putative model is supported by some stud-
ies, others suggest another model that presumes the
redundancy of the second enveloping by deducing that
the viral capsids are directly transported to the Golgi
secretory pathway and out of the cell by exocytosis [25].
Certainly, no matter which of the two models is more
plausible, both basically involve the premise that the
enveloping of viral capsids requires interactions of capsid
components with the cytoplasmic membrane [26]. In this
context, the efficiency and rate of viral capsid enveloping
are likely to contribute to the control of the efficiency and
rate of viral replication.
The studies of HSV-1 VP26 demonstrate that this pro-
tein is similar to other viral proteins that are not abso-
lutely required for viral replication [9]. However, from the
viewpoint of evolution it does not follow that VP26 would
maintain high copy numbers but not be functional in
capsids. Thus, it is not surprising that the interactions of
VP26 with several cellular proteins in the yeast two-
hybrid assay were observed. We also confirmed that
Figure 6 Morphological analysis on HSV-1 capsids aggregating in the cell with CTMP-7 expression inhibited (X30, 000). KMB-17 cells trans-
fected with pGE-1 or pGE-CTMP plasmid were infected at an MOI of 1 with HSV-1 and incubated at 37°C. At 48 hour post-infection, samples of cell 
were harvested, and the enveloping process of viral capsids was observed by electron microscopy. a. HSV-1 capsids were observed aggregating in 
the area closing to nuclear membrane (NM) of cells transfected by pGE-CTMP. b. HSV-1 capsids were localized separately in nuclear and cytoplasma 
of cells transfected by pGE-1 mock plasmid. c. HSV-1 capsids were counted in difference EM fields. n = 3 for all fields. Error bars represent the standard 
error of the mean.Wang et al. Virology Journal 2010, 7:156
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Figure 7 VP26 mutant virus shows a delayed proliferation. The recombinant virus HSV1-UG with a GFP-UL35 fusion gene was used to infect Vero 
or KMB-17 cells at 1 MOI. Punctated fluorescence spots were observed in the nucleus during infection, which is similar to the recombinant HSV1 with 
GFP-Vp16 fusion gene ([31]). At 12, 22, 24, 27, 36, 46, 60 and 72 h post-infection, samples of cell infected by HSV1-UG were collected and measured 
by real-time PCR with specific primers against α-4 gene. n = 3 for all time points. Error bars represent the standard error of the mean. Meanwhile, the 
KMB-17 cells infected by HSV1-UG were fixed with 5% glutaraldehyde and observed under the electron microscope. a. The Vero cells infected by VP26 
mutant HSV1-UG were observed under fluorescence microscope at 12, 16 and 24 h. b. Growth curve of HSV1-UG compared with that of wild type 
HSV-1 in Vero cells. c. Electro-microscope observation of cells infected by HSV1-UG(X30, 000).Wang et al. Virology Journal 2010, 7:156
http://www.virologyj.com/content/7/1/156
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VP26 interacted physically with CTMP-7, a tetraspanin
superfamily member consisting of typical transmem-
brane structures. Furthermore, as shown in co-immuno-
precipitation assays performed on HSV-1 infected cells,
the VP26-CTMP-7 complex was detected equally in
infected cells by either anti-VP26 antibody or CTMP-7
antibody. These results allow us to hypothesize a poten-
tial biological significance of VP26 binding to CTMP-7
for the HSV-1 infectious process. It may seem unlikely
that VP26 would mediate a series of functions by binding
to the C-terminus of CTMP-7, which only contains 12
amino acid residues. However, the reported finding that
the HTLV-1 Gag protein could bind to a 5 amino acid
domain of CD82 (another tetraspanin member) and use
this interaction to enter the host cell suggests the VP26-
CTMP-7 interaction is possible [27].
The distribution of CTMP-7 in normal fibroblasts visu-
alized by fusion to a GFP protein showed that it was a
typical cellular membrane protein diffused on the surface
of the nuclear and cytoplasmic membranes (Fig. 2a). This
distribution was altered remarkably by fluorescent parti-
cles in diffused punctate patterns moving away from the
cytoplasma at 24 h in HSV-I infection, about the time a
replication cycle of this virus would be completed
(Fig.2a). With the viral infection extended to 30 h, the
GFP-fused CTMP-7 molecules on infected cytoplasmic
membrane gradually tended to disappear as compared to
that on non-infected cytoplasmic membrane compared
with GFP control cells in cytometric analysis (Fig. 2b).
Additionally, CTMP-7 molecules were visualized in puri-
fied HSV-1 virions in Western blot by antibody against
CTMP-7, and Western blot of purified virion proteins by
anti-HSV1 antibody confirmed this obversation
(Fig.3a,b), corresponding to the disappearance of CTMP-
7 from the cells during the progress of viral infectivity
(Fig.3a). It remains unclear whether CTMP-7 packaged in
virions would function in the initial process of viral infec-
tion. The data described herein strongly support the
hypothesis that the interaction of VP26 with CTMP-7
plays an essential role in accomplishing normal viral rep-
lication. Based upon this hypothesis, our study examined
the effects of inhibiting CTMP-7 expression by two spe-
cific RNAi molecules produced by the pGE-CTMP vector
in infected cells. We provided further evidence of the
functional role of CTMP-7 by observing a significant
decrease in the HSV-1 replication rate when CTMP-7
expression was inhibited (Fig.4-b). Moreover, as shown
by real-time quantitative PCR analysis, delayed viral
enveloping likely leads to a reduced number of mature
virions egressing from the infected cell as compared to
that of normal cells in the same period of time (Fig. 5a, b,
c). The detection of α, β, and γ gene copy numbers in
infected cell supernatant and precipitation of the control
and experimental groups revealed no remarkable correla-
tion between decreasing viral replication rate and gene
transcription and replication processes in cells with
C T M P - 7  R N A i  t r e a t m e n t .  I n s t e a d ,  t h i s  o b s e r v e d
decrease in viral replication is probably attributed to inhi-
bition of capsid enveloping and egress of viral particles.
As further demonstrated by our electron-microscopic
observations, in the absence of CTMP-7 the capsid envel-
oping was stopped temporarily and capsids were aggre-
gated in the nucleus (Fig. 6a, b). Nevertheless, our
experiments indicated that the number of virions egress-
ing was increased again at later infectious stages (36 h
post-infection) regardless of the initial impact of CTMP-7
absence on capsid enveloping (Fig.5-c). This observation
suggests that HSV-1 may have other compensating strate-
gies to overcome the delay of viral infectious cycles due to
capsids aggregating in the nucleus in the absence of
CTMP-7.
The tetraspanin superfamily member proteins are
broad transmembrane proteins with physiological func-
tions associated with many signal transduction pathways
and pathological processes of many infectious diseases
[28]. The infectious and proliferative processes of some
RNA viruses such as HIV, HTLV-1 and HCV are pro-
posed to associate with tetraspanin molecules as well
[27,29,30]. The findings in this study will enable better
understanding of the biological mechanisms of HSV-1
viral capsid enveloping mediated by interactions of
CTMP-7 and VP26.
Conclusion
We demonstrated the interaction of VP26 with cellular
CTMP-7 in our in vivo and in vitro experiments. In addi-
tion, analysis of recombinant virus HSV-1-UG showed
that mutating VP26 resulted in a decreased viral replica-
tion rate and aggregation of viral mutant capsids in the
nucleus. Together, our data lend support to the conclu-
sion that the biological events mediated by VP26 inter-
acting with CTMP-7 aid in the viral capsid enveloping
and egress from the cell during the HSV-1 infectious pro-
cess.
Methods
Cells and Virus
KMB17 human embryo fibroblasts (passage 27, Institute
of Medical Biology, CAMS), Vero cells (passage 219,
ATCC) and Hela cells were grown in Dulbecco's Modified
Eagle's Medium (DMEM) (Gibco, Grand Island, NY,
USA) supplemented with 50 mmol/L L-glutamine
(Sigma, St. Louis, MO, USA) and 10% (v/v) of fetal bovine
serum (FBS, Gibco) and incubated in 5% CO2 at 37°C.
Chinese hamster ovary (CHO) cells were grown in com-
plete Ham's F12 media containing 5% fetal calf serum
under 5% CO2 at 37°C. Herpes simplex virus 1 (F strain
obtained from the Institute of Virology, Beijing) wasWang et al. Virology Journal 2010, 7:156
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grown in Vero cells and titered in the same cells with a
micro-titration assay.
Plasmid Construction
Vectors pcDNA (Invitrogen, Grand Island, NY, USA),
pGFP-N (Invitrogen), pGE-1, pGE-Neg (Stratagene),
pGBK-T7 (Clontech, Palo Alto, CA, USA) and pBV220
(China CDC) were produced and purified according to
standard protocols for further plasmid construction. The
primers used to obtain the sequences of the UL35 gene
and cellular tetraspanin membrane protein 7 (CTMP-7)
were as Table. 1. pGBK-Vp26 was constructed with
pGBK-T7 and the encoding sequence of UL35. pcDNA-
UL35 was constructed by pcDNA-3 and the encoding
sequence of UL35. pGFP- CTMP was constructed with
pGFP-N and the encoding sequence of CTMP-7.
pcDNA-CTMP was constructed by pcDNA-3 and the
encoding sequence of CTMP.
Yeast two-hybrid screen and β-galactosidase assay
The cDNA of UL35 was cloned into pGBK-VP26 as a
Gal4 DNA-binding domain fusion. This construct was
used to screen a pre-transformed human liver cDNA
library (BD Biosciences Clontech). Approximately 104
transformants were screened according to the manufac-
turer's protocol. The positive clones were identified twice
on synthetic dropout agar plates lacking leucine, trypto-
phan, histidine and adenine (QDO) and were cloned and
sequenced. The β-galactosidase assay was performed to
compare the relative strength of interaction between
VP26 protein and selected proteins with the substrate o-
nitrophenyl-β-D-galactosidase (ONPG, Sigma). β-galac-
tosidase units were calculated using the formula: β-galac-
tosidase units = 1000 × A420/(t × V × A600). T = elapsed
time of incubation (min); V = 0.1 ml × concentration fac-
tor; A600 = A600 of 1 ml of culture.
Co-immunoprecipitation of VP26 and CTMP-7 in vivo
Co-immunoprecipitation of VP26 and CTMP-7 was per-
formed according to a standard protocol. Vero cells
grown in DMEM with 5% FBS to 90% confluence in six-
well plate were washed twice with serum-free DMEM
and were transfected with 2 ug/well of pcDNA-
UL35Invitrogen) After transfection, the cells were recov-
ered in DMEM supplemented with 5% FBS for 24 h. Sub-
sequently, the transfected cells were incubated in DMEM
at 37°C and maintained in the same media for more than
8 h. The cells were rinsed twice with PBS and scraped in
100 μl of modified RIPA buffer (150 mmol/L NaCl, 1%
Brij-96, 0.5% deoxycholic acid, 50 mmol/L Tris-HCl pH
7.5), and freeze-thawed 3 times. After centrifugation at
12,500 rpm for 10 min at 4°C, the supernatant was incu-
bated with an anti-VP26 monoclonal antibody (Upstate
Biotechnology) or with an anti-CTMP-7 (VP26 interact-
ing protein) polyclonal antibody in RIPA buffer at 37°C
for 1 h. The A protein-Sepharose 4B (Sigma) was added
for further incubation at 4°C for 1 h. After washing 3
times with washing buffer (50 mmol/L, 1% Brij-96, 0.1%
SDS, 50 mmol/L tris-HCL, pH7.5) and centrifugation as
above, the A protein-Sepharose 4B absorbed immune
complex pellet was incubated in SDS sample buffer (2%
SDS, 62.5 mmol/L Tris, 10% glycerol, 2% 2-mercaptoeth-
anol pH 6.8) at 100°C for 5 min. The supernatant was
subjected to SDS-PAGE followed by electrophoresis and
transferred to NC membrane. Finally, the membrane was
used for further Immunoblot by anti-CTMP antibody.
Fluorescence Detection of CTMP-7
Vero cells plated in 6-well plates at 90% confluence in
DMEM supplemented with 10% FBS were transiently
transfected with control plasmid pGFP-N and expression
plasmids pGFP-CTMP using Lipofectamine Plus reagent
(Invitrogen). All cell samples were viewed under a fluo-
rescence microscope 36 h after transfection. For analysis
of the effect of CTMP-7 in the HSV-1 infected cell, KMB-
17 cells pre-transfected with pGFP-CTMP was infected
with HSV-1 at 0.2 multiplicity of infection (MOI). At 12,
24, 36, 48, 60 and 72 h post-infection, the cells were
trypsinized, washed in PBS and analyzed by flow cytome-
ter (Facs Canto II, BD).
Virus purification
Herpes simplex virus 1 harvested from Vero cells was first
centrifuged at 3,500 rpm for 20 min. 1M ZnAc2 was then
added to the resulting supernatant to yield ZnAC2 con-
centration of 20 mM. The mixture was incubated at 4°C
for 30 min and then centrifuged at 10,000 rpm for 30 min
to collect the precipitate which contained HSV-1. HSV-1
was further purified by sucrose density gradient centrifu-
gation. Briefly, a 0.5 mL sample was applied to a 20% to
50% linear sucrose gradient (containing 20 mmol/L Tris-
HCl plus 150 mmol/L NaCl, 10 mmol/L MgCl2, 1% NP-
40) prepared in a 5 mL centrifuge tube. Gradients were
centrifuged for 5 h at 45,000 rpm at 4°C. The gradient was
fractionated, and identified by OD280nm.
Viral growth kinetics analysis
A one-step growth curve was produced to determine
whether CTMP-7 had an effect on HSV-1 virus prolifera-
tion. KMB-17 cells were infected with HSV-1 virus at an
MOI of 1 in the presence or absence of CTMP-7. The
infected cell supernatants were harvested at the indicated
times and the titer was determined by microtitration.
RNA interference (RNAi) of CTMP-7 gene expression
RNAi-mediated reduction of the CTMP-7 gene expres-
sion in KMB-17 cells was performed with a specific dou-
ble stranded small hairpin RNA (shRNA) fragment
against the gene encoding CTMP-7. Two siRNA frag-Wang et al. Virology Journal 2010, 7:156
http://www.virologyj.com/content/7/1/156
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ments were against the nucleotides 179 to 208 and 553 to
582 of the CTMP-7 gene respectively:
5'-GGATCCCGCAGGCCAAAGACAACAATAGT
GGTGCCAGTCAAGAGCTGGCACCACTATTGTTG
TCTTTGGCCTGtcgtcagctcgtgccgtaag
TGAAACTAGTTACCAGATCATAACAACCCTCA
AGAGGGTTGTTATGATCTGGTAACTAGTTTCA
TTTTTTCTAGA-3' was inserted into pGE-1 to be as
pGE-CTMP. In addition, a scrambled interfering RNA
was used as the negative control. The sequences were
produced with the pGE-1 vector. Beginning twenty-four
hours after transfection, cells were harvested at the desig-
nated time points (usually 0, 6, 12, 24, 48, 72 and 96 h),
and the expression of CTMP-7 protein was detected in
KMB-17 cells by Western blot with the antibody against
CTMP-7.
Quantitative real-time PCR
For each sample, 500 ng of the DNA was used after purifi-
cation from clarified supernatant of HSV-1 infected cells
using the QiaAmp DNA Blood Mini Kit (Qiagen) as per
the manufacturer's protocol. As a set of internal stan-
dards, the HSV-1 virus was serially diluted to known con-
centrations in the range of 101 to 107 molecules per μL
with the total concentration of DNA in each adjusted to
50 μg/mL with salmon sperm DNA. PCR reactions were
prepared using the SYBGRN PCR kit (TOYOBO) in 20
μL volumes. Primers for amplification of a-4 (amplicon
size: 80 bp), tk (amplicon size:111 bp) and gC gene (ampl-
icon size:108 bp) were 5'- GGAGACGTCGTCACGGC-
CGG -3' and 5'- TCGTTGCCGTCGTCGTCCTC -3', 5'-
AGGCATGCCCATTGTTATCTG -3' and 5'- GAGA-
CAATCGCGAACATCTAC -3', 5'- ATTCCACCCGCA
TGGAGTTC -3' and 5'- CGGTGATGTTCGTCAG-
GACC -3', respectively. Reactions were run in a 96-well
format in an ABI Prism 7500 with the following condi-
tions: 95°C for 15 min, followed by 95°C for 15 s, 60°C for
1 min and repeated for 30 cycles. Cts were determined as
the first cycle where fluorescence was 10 times back-
ground.
Western blot
W e s t e r n  b l o t  w i t h  t h e  a n t i b o d y  p r o d u c e d  b y  t h e
expressed CTMP-7 protein was performed to detect the
expression of CTMP-7 according to standard protocol.
As an internal control, mouse monoclonal anti-β-actin
antibody (diluted 1:200; Santa Cruz Biotechnology, Santa
Cruz, CA) was used. The secondary antibody, anti-mouse
IgG, was purchased from Sigma. Nitroblue tetrazolium
(NBT; Sigma) was used as the substrate to detect reactiv-
ity.
Construction of VP26-EGFP fusion protein recombinant 
virus
Briefly, cells were infected with HSV-1 (MOI = 0.1) and
transfected at 30 min post-infection with pGFP-UL35N-
GFP-UL35C. The infection was allowed to proceed for 2
to 3 days before cells were harvested. Confirmation of the
presence of GFP was obtained by performing PCR with
primers that flank the transcriptional start site of the
UL35 gene. Products of 320 bp and 1123 bp were ampli-
fied from recombinant viruses and non-recombinant
viruses, respectively. These viruses were then subjected
to two rounds of plaque purification.
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